Vanda Pharmaceuticals
VNDA
VNDA
185 hedge funds and large institutions have $1.34B invested in Vanda Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 61 increasing their positions, 58 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
1.4% more ownership
Funds ownership: 99.67% → 101.07% (+1.4%)
5% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 58
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Holders
185
Holding in Top 10
4
Calls
$7.34M
Puts
$5.84M
Top Buyers
| 1 | +$23.5M | |
| 2 | +$12.1M | |
| 3 | +$11.1M | |
| 4 |
Millennium Management
New York
|
+$7.66M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$7.08M |
Top Sellers
| 1 | -$20.7M | |
| 2 | -$9.87M | |
| 3 | -$7.76M | |
| 4 |
HRCM
Hawk Ridge Capital Management
Los Angeles,
California
|
-$5.94M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$5.82M |